Corpus Intelligence IC Memo — BRENTWOOD BEHAVIORAL HEALTHCARE 2026-04-26 05:27 UTC
IC Memo — BRENTWOOD BEHAVIORAL HEALTHCARE
Investment Committee Memorandum | MS | 105 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BRENTWOOD BEHAVIORAL HEALTHCARE

CCN 254007 | RANKIN, MS | 105 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BRENTWOOD BEHAVIORAL HEALTHCARE is a 105-bed safety-net/medicaid heavy in RANKIN, MS with $23.9M in net patient revenue and a -4.7% operating margin. The hospital serves a payer mix of 1.1% Medicare, 82.5% Medicaid, and 16.3% commercial.

Thesis: Undervalued. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.7% to 2.7% (+736bps).

Net Revenue HCRIS$23.9M
Current EBITDA COMPUTED$-1.1M
Operating Margin COMPUTED-4.7%
Occupancy HCRIS48.0%
Revenue / Bed COMPUTED$228K
Net-to-Gross HCRIS62.4%
Distress Probability ML70.8%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
26
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -4.7% places it above the state median. Among 26 size-comparable peers (52-210 beds), the median margin is -3.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-210), prioritizing same-state peers. 26 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BRENTWOOD BEHAVIORAL HEALTHCAR (Target)MS105$23.9M-4.7%
BAPTIST MEM HOSPITAL NORTH MISMS195$229.4M0.7%
BAPTIST MEM HOSPITAL GOLDEN TRMS154$221.1M6.9%
MAGNOLIA HOSPITALMS158$161.6M-4.7%
MERIT HEALTH WESLEYMS121$140.9M1.3%
RIVER OAKS HOSPITALMS158$124.1M7.0%
SOUTHWEST MS REGIONAL MED CENTMS97$123.1M-16.0%
RUSH FOUNDATION HOSPITALMS191$122.0M-19.1%
BAPTIST MEM HOSPITAL UNION COUMS83$117.9M3.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$503K+210bp18mo
Cost to Collect4.5%2.5%$479K+200bp12mo
Denial Rate Reduction12.0%6.5%$474K+198bp12mo
A/R Days Reduction5200.0%3800.0%$291K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$503K
Cost to Collect
$479K
Denial Rate Reduction
$474K
A/R Days Reduction
$291K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.8M
Current EBITDA$-1.1M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$643K
Current Margin-4.7%
Pro Forma Margin2.7%
WC Released (1x)$918K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.7M$10.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.7M$10.7M0.00x-100.0%
Bull Case9.0x11.0x$-1.6M$16.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.6M$17.0M0.00x-100.0%
Bear Case11.0x10.0x$-1.9M$2.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.9M$1.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (82.5%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 70.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 26 hospitals with 52-210 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-16.0% / P50=-3.6% / P75=3.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.